NumFin

Standard BioTools Inc.

Symbol: LAB

NASDAQ

2.41

USD

Market price today

  • -2.5738

    P/E Ratio

  • -0.0737

    PEG Ratio

  • 923.15M

    MRK Cap

  • 0.00%

    DIV Yield

Standard BioTools Inc. (LAB) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Standard BioTools Inc. (LAB). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Standard BioTools Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062001

balance-sheet.row.cash-and-short-term-investments

0114.9165.828.5
68.5
58.6
95.4
63.1
59.4
95
115.3
84.3
80
53.5
5.7
14.6
17.8
40.4
25.5
0

balance-sheet.row.short-term-investments

063.284.50
0
37
0
5.1
24.4
65.9
81.6
49.1
21.4
39.9
0
0
0
6.3
0.5
0

balance-sheet.row.net-receivables

019.717.318.3
25.4
19
16.7
15
14.6
25.5
22.4
10.6
12.9
9.3
8.1
8.7
4.7
1.9
1.8
0

balance-sheet.row.inventory

020.521.520.8
19.7
13.9
13
15.1
20.1
17.9
16
8.1
7.2
6
4.9
3.9
5.5
5.5
3
0

balance-sheet.row.other-current-assets

03.14.34.5
4
4.6
2.1
1.5
2.5
5.7
2.2
1.5
1.1
1.3
2.2
1.2
1.3
2.6
0.8
0

balance-sheet.row.total-current-assets

0158.2208.872.1
117.7
96.1
127.1
94.8
96.7
144.1
155.9
104.6
101.2
70
20.9
28.5
29.2
50.3
31.1
0

balance-sheet.row.property-plant-equipment-net

054.959.565.2
55.6
12.9
8.8
12.3
16.5
15.3
13.9
6.8
5
3.3
2.3
1.9
2.8
3.4
4.1
0

balance-sheet.row.goodwill

0106.3106.3106.4
106.6
104.1
104.1
104.1
104.1
104.1
104.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

01.412.627.9
40.2
46.2
57.4
68.6
79.8
91
102.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0107.7118.9134.3
146.8
150.3
161.5
172.7
183.9
195.2
206.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

00.811
1
1
0
0
0
6.5
27.5
1.9
3.7
2.8
1.3
0
0
0
0
0

balance-sheet.row.tax-assets

00-1-1
-1
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

01.53.13.7
4.7
5.5
6.2
7.5
9.3
10.1
4
3.6
3.9
3.2
0.3
1.7
0.4
1.1
1.3
0

balance-sheet.row.total-non-current-assets

0164.9181.5203.1
207.1
168.7
176.5
192.6
209.7
227
251.7
12.3
12.5
9.3
3.9
3.7
3.1
4.4
5.4
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0323.1390.3275.2
324.8
264.8
303.6
287.4
306.4
371.1
407.6
116.9
113.7
79.3
24.8
32.2
32.4
54.8
36.5
0

balance-sheet.row.account-payables

09.27.910.6
9.2
6.5
4
4.2
4
6.1
5.9
4.4
2.6
4
3.2
2.2
2.9
2.7
1.2
0

balance-sheet.row.short-term-debt

063.95.89.9
3
1.8
0
0
0
0
0
-0.7
0
8.9
7.7
3.5
1
3.8
3.5
0

balance-sheet.row.tax-payables

01.21.21.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-54.1

balance-sheet.row.long-term-debt-total

0496.9101.8
92.4
58.1
172.1
195.2
195
195.7
195.5
0
0
1.2
10.1
14.5
14.2
10.5
22.4
0

Deferred Revenue Non Current

014.318.224.1
29
8.2
6.3
5
4.3
4.4
4.4
1.9
1.2
0.7
0.4
0.3
0.3
0.8
0.8
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

020.615.313.6
28.6
12.7
22.1
19
16.4
14.6
16.5
10.9
7.2
5.2
6.3
0.6
3.2
2.4
1.5
0

balance-sheet.row.total-non-current-liabilities

050.5428.3131.1
131.5
78.4
193.9
222.9
223.7
226.1
227.8
2.5
1.5
2.3
195.5
198.6
182.2
173.5
135.5
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

030.437.840.6
41.2
6.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0159.9471.8180.6
185.7
111.2
231.5
256.4
253.2
256.2
257.1
19.8
13.1
22.4
214
205.8
190.7
185.1
142.7
-54.1

balance-sheet.row.preferred-stock

0311.3311.30
0
0
0
0
0
0
0
0.7
0
79.3
1.1
0
0
0
0
0

balance-sheet.row.common-stock

00.10.10.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-1000.8-926.1-736
-676.8
-623.6
-558.9
-500.2
-439.5
-363.5
-310.2
-257.3
-240.8
-221.8
-199.3
-182.4
-163.3
-133.8
-108.3
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-2.2-1.9-0.9
0.1
-0.6
-0.7
-0.6
-0.8
-1.1
-0.8
-0.7
-0.8
-0.8
-0.8
-0.5
-0.6
-0.1
0
0

balance-sheet.row.other-total-stockholders-equity

0854.8535.2831.4
815.6
777.8
631.6
531.7
493.4
479.5
461.4
354.5
342.2
200.1
9.9
9.3
5.5
3.6
2.1
0

balance-sheet.row.total-stockholders-equity

0163.2-81.594.6
139.1
153.6
72.1
30.9
53.2
114.9
150.4
97.1
100.7
56.9
-189.2
-173.6
-158.3
-130.3
-106.2
0

balance-sheet.row.total-liabilities-and-stockholders-equity

0323.1390.3275.2
324.8
264.8
303.6
287.4
306.4
371.1
407.6
116.9
113.7
79.3
24.8
32.2
32.4
54.8
36.5
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0163.2-81.594.6
139.1
153.6
72.1
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

06484.51
1
37
0
5.1
24.4
72.3
109.1
51
25
42.8
1.3
0
0
6.3
0.5
0

balance-sheet.row.total-debt

098.2102.7111.6
95.4
60
172.1
195.2
195
195.7
195.5
0
0
10.1
17.8
14.5
15.2
14.4
25.9
0

balance-sheet.row.net-debt

046.521.383.2
26.9
38.3
76.7
137.2
159.9
166.6
161.7
-35.3
-58.6
-3.4
12.1
-0.1
-2.6
-19.7
0.9
0

Cash Flow Statement

The financial landscape of Standard BioTools Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062001

cash-flows.row.net-income

0-74.7-190.1-59.2
-53
-64.8
-59
-60.5
-76
-53.3
-52.8
-15.8
-19
-22.5
-16.9
-19.1
-29.5
-25.5
-23.6
-59.2

cash-flows.row.depreciation-and-amortization

015.21515.6
15.9
15.8
16.6
18.6
17.9
16.1
4.1
2.6
1.5
1.1
1.5
1.9
2
2.1
1.5
11.9

cash-flows.row.deferred-income-tax

06.300
0.2
12.6
0.1
0
0
-2.3
-0.3
-1.8
0
23.4
0
-1.9
0
0
0
4.3

cash-flows.row.stock-based-compensation

013.114.916.1
14.5
11.4
11
9.1
13.9
16.8
20.9
6.4
4.1
2.8
1.6
2.1
2
0.7
0.1
4.9

cash-flows.row.change-in-working-capital

01.8-15.5-19.9
2.4
-13.2
-2.5
9.2
4.8
-8.2
-7.8
6.7
-4.1
-1
1.9
-2.7
-2.5
0.5
-1.2
49.7

cash-flows.row.account-receivables

0-31.16.7
-7.6
-2.1
-1.8
-0.6
10.5
-2.8
-3.4
2.4
-3.7
-1.2
0.2
-4
-3.3
-0.1
-0.4
18.3

cash-flows.row.inventory

0-4.9-8.5-4.8
-8.6
-2.7
1.5
4.6
-3.4
-3.7
-6.2
-1.5
-1.7
-1.1
-1
1.5
0
-2.5
-1
20.8

cash-flows.row.account-payables

01.6-2.81.3
3.4
2.1
-0.3
0.6
-2.3
0.8
0.1
1.8
-1.8
0.5
0.9
-0.6
0.1
1.5
-0.6
10.6

cash-flows.row.other-working-capital

08.1-5.3-23.2
15.3
-10.6
-1.9
4.6
-0.1
-2.5
1.6
4
3.1
0.8
1.7
0.5
0.7
1.6
0.7
-49.7

cash-flows.row.other-non-cash-items

0-586.33.4
4.6
3.1
8.6
-0.5
0.3
-3.8
13.4
0.3
0.1
-21.3
0.4
0.1
-0.8
0.3
0.8
-55.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2.8-3.8-13.3
-12.7
-2.5
-0.4
-1.6
-5.1
-10.7
-7.4
-4.7
-2.4
-1.7
-1.5
-0.8
-0.9
-1
-2.9
-13.3

cash-flows.row.acquisitions-net

0084.30
-5.2
36.8
0
0.1
2.3
-2.3
-112.9
3.1
-14
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-94.9-137.30
0
-62.4
-1.4
-6.3
-38.6
-67
-132.6
-59.4
-35.4
-71.4
0
0
-4.5
-6.3
-2
0

cash-flows.row.sales-maturities-of-investments

0118530
36.8
25.6
6.5
25.6
86.4
103.4
74.5
33.4
51.8
30
0
0
10.8
0.5
2
0

cash-flows.row.other-investing-activites

00-84.31.3
21
-36.8
0
-0.1
0
2.3
0
0
14
-2
0.2
0.1
0.6
0
0
1.3

cash-flows.row.net-cash-used-for-investing-activites

020.2-88.1-11.9
40
-39.3
4.7
17.7
45.1
25.7
-178.4
-27.6
14
-45.1
-1.3
-0.7
6
-6.7
-2.9
-11.9

cash-flows.row.debt-repayment

0-2.1-6.8-0.5
0
-51.8
0
0
0
0
0
0
-12.1
-12.9
0
-1
-3.9
-3.5
-4
0

cash-flows.row.common-stock-issued

00.82251.5
20.2
2.1
59.5
29
0.1
0
78.2
0
56
76.9
7.4
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-5.4-0.6-1.8
-0.5
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
-0.1
0

cash-flows.row.dividends-paid

000-0.3
0
-1.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-0.113.217.1
1.1
54.6
-1.8
0
0
5.3
122.1
5.8
4.6
6.3
-3.6
18
10.2
41.1
35.2
16

cash-flows.row.net-cash-used-provided-by-financing-activities

0-6.8230.816
20.9
2.8
57.7
29
0.1
5.3
200.3
5.8
48.5
70.4
3.8
16.9
6.3
37.6
31.1
16

cash-flows.row.effect-of-forex-changes-on-cash

00-0.40
0.4
0.1
0.2
0.5
-0.2
-0.9
-0.9
0
0.1
0.1
0.2
0.1
0.1
0
0
0

cash-flows.row.net-change-in-cash

0-29.652.9-40.1
45.8
-71.7
37.3
23
5.9
-4.6
-1.5
-23.4
45.1
7.8
-8.9
-3.2
-16.3
9.1
5.9
-40.1

cash-flows.row.cash-at-end-of-period

051.782.329.5
69.5
23.7
95.4
58.1
35
29.1
33.7
35.3
58.6
13.6
5.7
14.6
17.8
34.1
25
29.5

cash-flows.row.cash-at-beginning-of-period

081.329.569.5
23.7
95.4
58.1
35
29.1
33.7
35.3
58.6
13.6
5.7
14.6
17.8
34.1
25
19.2
69.5

cash-flows.row.operating-cash-flow

0-43.3-89.4-44.1
-15.4
-35.2
-25.2
-24.1
-39.1
-34.7
-22.6
-1.6
-17.5
-17.5
-11.5
-19.5
-28.7
-21.8
-22.3
-44.1

cash-flows.row.capital-expenditure

0-2.8-3.8-13.3
-12.7
-2.5
-0.4
-1.6
-5.1
-10.7
-7.4
-4.7
-2.4
-1.7
-1.5
-0.8
-0.9
-1
-2.9
-13.3

cash-flows.row.free-cash-flow

0-46.1-93.2-57.3
-28.1
-37.7
-25.6
-25.7
-44.2
-45.3
-30
-6.3
-19.9
-19.2
-13
-20.3
-29.6
-22.7
-25.2
-57.3

Income Statement Row

Standard BioTools Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of LAB is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062001

income-statement-row.row.total-revenue

0106.397.9130.6
138.1
117.2
113
101.9
104.4
114.7
116.5
71.2
52.3
42.9
33.6
25.4
15.3
7.3
6.4
130.6

income-statement-row.row.cost-of-revenue

055.960.961.2
54.8
53
51.3
50
46
46.6
42.8
20.1
15.3
13.2
11.6
11.5
8.4
3.5
2.8
53.3

income-statement-row.row.gross-profit

050.537.169.4
83.3
64.3
61.6
52
58.4
68.1
73.6
51.1
37
29.7
22
13.9
7
3.8
3.6
77.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

07-12.37.6
0.5
1.4
0.6
0.4
-1.2
-1.2
-0.9
0.5
-0.2
0
0
0
0
0
0
7.9

income-statement-row.row.operating-expenses

0113.5153.3136.8
134.4
116.1
109.8
110.3
131.6
122.2
114.7
67.8
55.1
45.2
36.6
32
36.5
27.3
25.3
144.7

income-statement-row.row.cost-and-expenses

0169.4214.2198
189.2
169.1
161.1
160.3
177.6
168.9
157.6
87.9
70.4
58.4
48.1
43.4
44.9
30.8
28.1
198

income-statement-row.row.interest-income

004.30.3
0.3
1.3
0
0
0
0
0
0
0
0
0
0
0.8
1.1
0.6
0

income-statement-row.row.interest-expense

04.64.33.8
3.6
4.3
13.9
5.8
5.8
5.8
5.3
0
0.6
3.1
2.2
2.9
2
2.8
2.3
-3.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-11.2-76.73.8
-3.1
-14.9
0.6
0.4
-1.2
5.2
-11.2
1
-0.2
-3.6
-0.1
1.7
1.2
-0.2
-0.2
3.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

07-12.37.6
0.5
1.4
0.6
0.4
-1.2
-1.2
-0.9
0.5
-0.2
0
0
0
0
0
0
7.9

income-statement-row.row.total-operating-expenses

0-11.2-76.73.8
-3.1
-14.9
0.6
0.4
-1.2
5.2
-11.2
1
-0.2
-3.6
-0.1
1.7
1.2
-0.2
-0.2
3.8

income-statement-row.row.interest-expense

04.64.33.8
3.6
4.3
13.9
5.8
5.8
5.8
5.3
0
0.6
3.1
2.2
2.9
2
2.8
2.3
-3.8

income-statement-row.row.depreciation-and-amortization

015.22.723.2
16.4
17.2
16.6
18.6
17.9
16.1
4.1
2.6
1.5
1.1
1.5
1.9
2
2.1
1.5
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-63-116.2-67.5
-51
-51.8
-48.2
-58.4
-73.2
-50.2
-51.8
-17.9
-18.1
-18.6
-14.6
-18
-29.5
-23.5
-21.7
-67.5

income-statement-row.row.income-before-tax

0-74.2-192.9-63.7
-54.1
-66.7
-61.4
-63.8
-80.2
-54.8
-57.7
-15.7
-18.9
-22.3
-16.8
-19.2
-29.6
-25.3
-23.6
-63.7

income-statement-row.row.income-tax-expense

00.5-2.8-4.4
-1.1
-1.9
-2.4
-3.3
-4.2
-1.5
-4.9
0.1
0.1
0.2
0.1
-0.1
-0.1
0.1
0.2
-4.4

income-statement-row.row.net-income

0-74.7-190.1-59.2
-53
-64.8
-59
-60.5
-76
-53.3
-52.8
-15.8
-19
-22.5
-16.9
-19.1
-29.5
-25.5
-23.6
-59.2
Similar Stocks
You may also be interested in:
8225.HK
China Health Group Inc..
0.119 HKD
HKSE
RVTY
Revvity, Inc..
104.34 USD
NYSE
IDXX
IDEXX Laboratories, Inc..
500.82 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.305 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.655 AUD
ASX
DGX
Quest Diagnostics Incorporated.
138.16 USD
NYSE
QIA.DE
Qiagen N.V..
40.345 EUR
XETRA
300685.SZ
Amoy Diagnostics Co., Ltd..
20.57 CNY
SHZ
603259.SS
WuXi AppTec Co., Ltd..
44.6 CNY
SHH
GTG.AX
Genetic Technologies Limited.
0.13 AUD
ASX

Frequently Asked Question

What is Standard BioTools Inc. (LAB) total assets?

Standard BioTools Inc. (LAB) total assets is 323067000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.472.

What is company free cash flow?

The free cash flow is -0.578.

What is enterprise net profit margin?

The net profit margin is -0.702.

What is firm total revenue?

The total revenue is -0.659.

What is Standard BioTools Inc. (LAB) net profit (net income)?

The net profit (net income) is -74656000.000.

What is firm total debt?

The total debt is 98210000.000.

What is operating expences number?

The operating expences are 113489000.000.

What is company cash figure?

Enretprise cash is 0.000.